Elective Discontinuation of Checkpoint Inhibitor Therapy in Patients with advanced Melanoma

被引：0
|
作者：
Persa, O. D. [1 ]
Schatton, K. [1 ]
Ruebben, A. [2 ]
Berking, C. [3 ]
Erdmann, M. [3 ]
Schlaak, M. [4 ]
Mauch, C. [5 ]
Steeb, T. [3 ]
机构：
[1] Uniklin Dusseldorf, Dusseldorf, Germany
[2] Uniklin Aachen, Aachen, Germany
[3] Uniklin Erlangen, Erlangen, Germany
[4] Charite Univ Med Berlin, Berlin, Germany
[5] Uniklin Koln, Cologne, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2021年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP 018
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [31] Rationale for New Checkpoint Inhibitor Combinations in Melanoma Therapy
    Mario Mandalà
    Carlo Tondini
    Barbara Merelli
    Daniela Massi
    American Journal of Clinical Dermatology, 2017, 18 : 597 - 611
  • [32] The neurotoxic effects of immune checkpoint inhibitor therapy for melanoma
    Spain, Lavinia
    Wong, Rachel
    MELANOMA MANAGEMENT, 2019, 6 (02)
  • [33] Rationale for New Checkpoint Inhibitor Combinations in Melanoma Therapy
    Mandala, Mario
    Tondini, Carlo
    Merelli, Barbara
    Massi, Daniela
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (05) : 597 - 611
  • [34] Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma
    Smart, A. C.
    Margalit, D. N.
    Tishler, R. B.
    Tanguturi, S.
    Aizer, A. A.
    Balboni, T. A.
    Ott, P.
    Hodi, F. S.
    Buchbinder, E.
    Schoenfeld, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E12 - E12
  • [35] Dermatomyositis Flare With Immune Checkpoint Inhibitor Therapy for Melanoma
    Thomas, Rachel
    Patel, Hamish
    Scott, Joshua
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [36] Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience
    Chuy, Katherine Lee
    Oikonomou, Evangelos K.
    Postow, Michael A.
    Callahan, Margaret K.
    Chapman, Paul B.
    Shoushtari, Alexander N.
    Neilan, Tomas G.
    Fradley, Michael G.
    Ramanathan, Lakshmi V.
    Wolchok, Jedd D.
    Steingart, Richard M.
    Gupta, Dipti
    ONCOLOGIST, 2019, 24 (05): : E196 - E197
  • [37] The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Bishay, Kirles
    Parlow, Simon
    Laurie, Scott A.
    McCurdy, Jeffrey D.
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (03) : 101 - 108
  • [38] Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
    Rieth, John M.
    Swami, Umang
    Mott, Sarah L.
    Zanaty, Mario
    Henry, Michael D.
    Bossler, Aaron D.
    Greenlee, Jeremy D.
    Zakharia, Yousef
    Vanneste, Marion
    Jennings, Brooke
    Milhem, Mohammed M.
    CANCERS, 2021, 13 (07)
  • [39] Dual Immune Checkpoint Inhibitor Therapy Is Associated With Increased Blood Pressure In Melanoma Patients
    Turker, Isik
    Sharma, Ananya
    Huang, Shi
    Johnson, Douglas
    Alexander, Matthew R.
    HYPERTENSION, 2022, 79
  • [40] Assessing the effects of probiotic supplementation in patients with metastatic melanoma on checkpoint-inhibitor therapy
    Vujevic, Andro
    Strikic, Dominik
    Plese, Sven
    Cegec, Ivana
    Turk, Viktorija Erdeljic
    Ausperger, Ksenija Makar
    Mikulic, Iva
    Aumiler, Matea Radacic
    Likic, Robert
    Mercep, Iveta
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 382 - 382
12345